This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cooper, C. Articles by Watson, P. H. Search for Related Content PubMed PubMed Citation Articles by Cooper, C. Articles by Watson, P. H.

Intermittent Hypoxia Induces Proteasome-Dependent Down-Regulation of Estrogen Receptor in Human Breast Carcinoma

Manitoba Institute of Cell Biology and Departments of ¹ Pathology and ² Biochemistry and Medical Genetics, University of Manitoba, Faculty of Medicine, Winnipeg, Manitoba, Canada; and ³ Department of Surgery, Cancer Hospital/Cancer Institute, Fudan University, Shanghai, China

Purpose: Hypoxia may influence gene expression to promote malignancy, and acute hypoxia has been shown to transiently repress estrogen receptor (ER)- expression in breast cell lines. However, the effect of intermittent hypoxia, which is likely more prevalent in breast cancers, remains to be determined.

Experimental Design: ER- expression was assessed by Western blot and immunohistochemistry in a selected cohort of 51 ER-–positive breast carcinomas, in relation to markers of hypoxia. The effect of acute and intermittent hypoxia on ER- expression was also determined in MCF7 and ZR-75 breast cell lines, together with the role of proteasome function with the proteasome inhibitor bortezomib.

Results: Regional loss of ER- expression occurs in breast tumors and is consistently present in hypoxic regions defined by the proximity of necrosis and induction of hypoxia-induced genes carbonic anhydrase IX (CA-IX) and glucose transporter 1 (Glut-1), in both in situ (n = 29; P < 0.0001) and invasive (n = 20; P = 0.0001) carcinomas. In MCF7 and ZR-75 cells, ER- is transiently down-regulated by acute hypoxia and rapidly restored by reoxygenation. However, intermittent, acute hypoxia can cause a similar down-regulation of ER- that is not attributable to decreased mRNA and persists in MCF7 cells despite reoxygenation for up to 14 days. This effect occurs with no change in cell viability but a corresponding reduction in growth response to estradiol. However, ER- expression can be restored by bortezomib.

Conclusions: Intermittent hypoxia can cause persistent changes in proteasome function that may contribute to reduced ER- expression in breast tumors and consequently to diminished response and development of resistance to endocrine therapy.

This article has been cited by other articles:

				D. Generali, S. B Fox, A. Berruti, M. P Brizzi, L. Campo, S. Bonardi, S. M Wigfield, P. Bruzzi, A. Bersiga, G. Allevi, et al. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 921 - 930. [Abstract] [Full Text] [PDF]